EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Current progress of cerebral organoids for modeling Alzheimer's disease origins and mechanisms

Sai Sreenivasamurthy, Mahek Laul, Nan Zhao, Tiffany Kim, Donghui Zhu iD

Bioengineering & Translational Medicine · 2023-03 · 8 (2)

DOI: 10.1002/btm2.10378 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Bioengineering & Translational Medicine, online erschienen am 02.08.2022. Verfasst von Sai Sreenivasamurthy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering Stony Brook University Stony Brook New York USA. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIGMS NIH HHS, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is a progressive, neurodegenerative disease that has emerged as a leading risk factor for dementia associated with increasing age. Two‐dimensional (2D) cell culture and animal models, which have been used to analyze AD pathology and search for effective treatments for decades, have significantly contributed to our understanding of the mechanism of AD. Despite their successes, 2D and animal models can only capture a fraction of AD mechanisms due to their inability to recapitulate human brain‐specific tissue structure, function, and cellular diversity. Recently, the emergence of three‐dimensional (3D) cerebral organoids using tissue engineering and induced pluripotent stem cell technology has paved the way to develop models that resemble features of human brain tissue more accurately in comparison to prior models. In this review, we focus on summarizing key research strategies for engineering in vitro 3D human brain‐specific models, major discoveries from using AD cerebral organoids, and its future perspectives.

Schlagwörter

Stichwörter der Autor:innen

amyloid betafamilial Alzheimer'sneurodegenerationneurofibrillary tanglesneurospheroidssporadic Alzheimer's

Autor:innen und Institutionen

  • Department of Biomedical Engineering Stony Brook University Stony Brook New York USA.
  • Institute for Nanobiotechnology Johns Hopkins University Baltimore Maryland USA.

ORCID-Profile: Donghui Zhu

Förderung

  • NIA NIH HHS
  • NIGMS NIH HHS
  • National Institute on Aging

Zitieren

APA

Sreenivasamurthy, S., Laul, M., Zhao, N., Kim, T., & Zhu, D. (2023). Current progress of cerebral organoids for modeling Alzheimer's disease origins and mechanisms. Bioengineering & Translational Medicine, 8(2). https://doi.org/10.1002/btm2.10378

Vancouver

Sreenivasamurthy S, Laul M, Zhao N, Kim T, Zhu D. Current progress of cerebral organoids for modeling Alzheimer's disease origins and mechanisms. Bioengineering & Translational Medicine. 2023;8(2). doi:10.1002/btm2.10378

BibTeX
@article{Sreenivasamurthy2023,
  author = {Sreenivasamurthy, Sai and Laul, Mahek and Zhao, Nan and Kim, Tiffany and Zhu, Donghui},
  title = {Current progress of cerebral organoids for modeling Alzheimer's disease origins and mechanisms},
  journal = {Bioengineering & Translational Medicine},
  year = {2023},
  volume = {8},
  number = {2},
  doi = {10.1002/btm2.10378}
}
Kostenlos starten →